Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP516053.RAnyGCWLkAnj3wQTeIjcjShDo-IDM6XlfnMQtbdUfhFwQ130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP516053.RAnyGCWLkAnj3wQTeIjcjShDo-IDM6XlfnMQtbdUfhFwQ130_assertion type Assertion NP516053.RAnyGCWLkAnj3wQTeIjcjShDo-IDM6XlfnMQtbdUfhFwQ130_head.
- NP516053.RAnyGCWLkAnj3wQTeIjcjShDo-IDM6XlfnMQtbdUfhFwQ130_assertion description "[On the basis of the methylation profile, CRBP1 and CDH13 methylation were good indicators of CIMP in NSCLC, and were correlated with a poorer prognosis in adenocarcinomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP516053.RAnyGCWLkAnj3wQTeIjcjShDo-IDM6XlfnMQtbdUfhFwQ130_provenance.
- NP516053.RAnyGCWLkAnj3wQTeIjcjShDo-IDM6XlfnMQtbdUfhFwQ130_assertion evidence source_evidence_literature NP516053.RAnyGCWLkAnj3wQTeIjcjShDo-IDM6XlfnMQtbdUfhFwQ130_provenance.
- NP516053.RAnyGCWLkAnj3wQTeIjcjShDo-IDM6XlfnMQtbdUfhFwQ130_assertion SIO_000772 16598760 NP516053.RAnyGCWLkAnj3wQTeIjcjShDo-IDM6XlfnMQtbdUfhFwQ130_provenance.
- NP516053.RAnyGCWLkAnj3wQTeIjcjShDo-IDM6XlfnMQtbdUfhFwQ130_assertion wasDerivedFrom befree-20140225 NP516053.RAnyGCWLkAnj3wQTeIjcjShDo-IDM6XlfnMQtbdUfhFwQ130_provenance.
- NP516053.RAnyGCWLkAnj3wQTeIjcjShDo-IDM6XlfnMQtbdUfhFwQ130_assertion wasGeneratedBy ECO_0000203 NP516053.RAnyGCWLkAnj3wQTeIjcjShDo-IDM6XlfnMQtbdUfhFwQ130_provenance.